BuyCancerDrugs.com BuyCancerDrugs.com
BuyCancerDrugs.com BuyCancerDrugs.com
OncologyJournal.org - The Latest Medical News and Information for Patients Diagnosed with Cancer
Search OncologyJournal.org
Browse by Cancer Type or Cancer Drug

Go Back   OncologyJournal.org - The Latest Medical News and Information for Patients Diagnosed with Cancer > Blogs > admin
Connect with Facebook


Cervical Cancer
Old

Drug and radiation treatment cuts deaths from cervical cancer

Posted 08-20-2010 at 03:48 PM by admin
Treating cervical cancer patients with both radiotherapy and drugs can reduce the risk of dying by almost a quarter, research has found.

By Rebecca Smith, Medical Editor
Published: 7:30AM BST 20 Aug 2010

An audit of patients treated in British cancer centres in 2001 and 2002 found those who received both chemotherapy and radiotherapy did better than those who were just treated with radiotherapy.

The audit was published by The Royal College of Radiologists...
Administrator
Comments 0 admin is offline
Old

PA Breast Cancer Coalition Announces Request for App. for Income Tax Research Grants

Posted 08-19-2010 at 06:26 PM by admin
The PA Breast Cancer Coalition Announces Request for Applications for Income Tax Research Grants

EPHRATA, Pa., Aug. 19 /PRNewswire-USNewswire/ -- Are you a breast or cervical cancer researcher in PA looking for additional research funding? The PA Breast Cancer Coalition (PBCC) is awaiting your grant application for the PBCC's Income Tax Refunds for Breast and Cervical Cancer Research Grants. The grant funding cycle is July 1, 2011– June 30, 2012.

To download the Request...
Administrator
Comments 0 admin is offline
Old

Advaxis Completes Dosing Vanguard Group in Phase II Cervical Dysplasia (CIN) Study

Posted 08-19-2010 at 06:20 PM by admin
August 18, 2010 11:11 AM Eastern Daylight Time

No Adverse Side Effects Were Observed After Initial Nine Doses

NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)--Advaxis, Inc., (OTCBB: ADXS), the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, has completed the nine (9) doses to be administered to the three (3) vanguard patients in the low dose group of its phase II cervical dysplasia clinical trial study.

As per the FDA approved design for...
Administrator
Comments 0 admin is offline
Old

New knowledge about cancer in HIV's survivors prompts warnings of an epidemic

Posted 08-18-2010 at 02:33 PM by admin
By Lois Wingerson | August 17, 2010

We cannot escape the realities of biology. Just as children rescued from leukemia and lymphoma live to grow into adults who must confront the adverse effects of their curative treatment, people rescued from AIDS by HAART (highly active antiretroviral therapy) are showing a substantially increased risk of cancers other than the "AIDS-defining" malignancies designated by the Centers for Disease Control in the 1980s: Kaposi sarcoma, non-Hodgkin lymphoma (NHL),...
Administrator
Comments 0 admin is offline
Old

1st Commercial Use of SpaceOAR Syst. for Prostate-Rectum Sep. in Prostate Cancer Pat.

Posted 08-13-2010 at 06:34 PM by admin
Augmenix Announces First Commercial Use of SpaceOAR™ System for Prostate-Rectum Separation in Prostate Cancer Patients Undergoing Radiation Therapy

WALTHAM, Mass., Aug. 11 /PRNewswire/ -- Augmenix, Inc. announced today that Prof. Michael Eble and Dr. Michael Pinkawa of the Aachen University Hospital, Aachen, Germany, performed a commercial implantation of the company's CE Mark approved SpaceOAR™ System. The SpaceOAR hydrogel (from spacing Organs At Risk) is designed to be a tissue...
Administrator
Comments 0 admin is offline


All times are GMT. The time now is 02:12 PM.


Powered by vBulletin® Version 3.8.1
Copyright ©2000 - 2010, Jelsoft Enterprises Ltd.